Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Telaprevir Exposure on the Severe Anemia Induced by Ribavirin/Pegylated Interferon/Telaprevir Tri-therapy in HCV Infected Patients

NCT01716403 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT01716403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01716403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Telaprevir Exposure on the Severe Anemia Induced by Ribavirin/Pegylated Interferon/Telaprevir Tri-therapy in HCV Infected Patients
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Terminated
Start date
October 31, 2012
Completion date
Not reported
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

c hepatitis, tri therapy